Andere talen Mydecine Innovations Group Inc. Deutsche Boerse AG

Aandelen

0NF0

CA62849F2008

Beurs gesloten - Deutsche Boerse AG Andere beurzen 08:00:06 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,01 ^EUR	0,00%		-33,33%	-23,08%

23/02	Mydecine Innovations rondt gedeeltelijke schuldregeling af	MT
02/02	Mydecine Innovations Group Inc kondigt aan dat Neil Stevenson-Moore ontslag heeft genomen als bestuurder	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Mydecine Provides Bl-Weekly Status Report	17/05
Mydecine Applies for Management Cease Trade Order	03/05
Mydecine Receives Management Cease Trade Order	03/05
Mydecine Innovations Group Inc. Announces Restructuring Transactions and Annual General and Special Meeting	02/05
Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding	01/05
Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order	26/04
Mydecine Innovations Group Inc. Announces Share for Debt Settlement	20/03
Mydecine Innovations Closes Partial Debt Settlement	23/02
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	07/02
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	07/02
Mydecine Innovations Group Announces Director Resignation	02/02
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	02/02
Mydecine Innovations Group Receives Notice of Allowance from USPTO For MYCO-005 Compound	18/12
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound	18/12
Mydecine Announces Update Regarding the Special Access Program	28/11
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18/11
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	31-10-23
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	31-10-23
Mydecine Innovations Group Provided Q4 2023 Business Update	26-10-23
Mydecine Provides Q4 2023 Business Update	26-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Mydecine Innovations Group Inc. Deutsche Boerse AG

Aandelen

0NF0

CA62849F2008

Andere talen

Filters